Antidepressive treatment with amitriptyline and paroxetine: effects on saliva cortisol concentrations. 2003

Michael Deuschle, and Bettina Hamann, and Cornelia Meichel, and Bertram Krumm, and Florian Lederbogen, and Anja Kniest, and Michael Colla, and Isabella Heuser
Central Institute of Mental Health, Mannheim, and dagger Department of Psychiatry, Free University of Berlin, Berlin, Germany. deuschle@as200.zi-mannheim.de

With regard to the course of basal human hypothalamus-pituitary-adrenal (HPA) system activity, there is a lack of data for comparing different classes of antidepressants. Ninety-four patients were included in a study comparing standardized treatment with paroxetine (PAROX) and amitriptyline (AMI) after a drug-free period of at least 6 days. Saliva for measurement of cortisol concentrations was obtained daily at 0800, 1600, and 2200 during the 6 days of drug-free washout and 35 days of active treatment. The course of HPA system activity and psychopathology, as assessed by the Hamilton Depression Scale, was compared by means of repeated-measurement analyses of variance (ANOVA-rm). Only AMI responders-not PAROX responders or nonresponders to either antidepressant-had a significant decline in saliva cortisol concentrations. In hypercortisolemically depressed patients, treatment with AMI may be preferable to PAROX in order to lower HPA system activity.

UI MeSH Term Description Entries
D007030 Hypothalamo-Hypophyseal System A collection of NEURONS, tracts of NERVE FIBERS, endocrine tissue, and blood vessels in the HYPOTHALAMUS and the PITUITARY GLAND. This hypothalamo-hypophyseal portal circulation provides the mechanism for hypothalamic neuroendocrine (HYPOTHALAMIC HORMONES) regulation of pituitary function and the release of various PITUITARY HORMONES into the systemic circulation to maintain HOMEOSTASIS. Hypothalamic Hypophyseal System,Hypothalamo-Pituitary-Adrenal Axis,Hypophyseal Portal System,Hypothalamic-Pituitary Unit,Hypothalamic Hypophyseal Systems,Hypothalamic Pituitary Unit,Hypothalamo Hypophyseal System,Hypothalamo Pituitary Adrenal Axis,Portal System, Hypophyseal
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010913 Pituitary-Adrenal System The interactions between the anterior pituitary and adrenal glands, in which corticotropin (ACTH) stimulates the adrenal cortex and adrenal cortical hormones suppress the production of corticotropin by the anterior pituitary. Pituitary Adrenal System,Pituitary-Adrenal Systems,System, Pituitary-Adrenal,Systems, Pituitary-Adrenal
D011569 Psychiatric Status Rating Scales Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness. Factor Construct Rating Scales (FCRS),Katz Adjustment Scales,Lorr's Inpatient Multidimensional Psychiatric Rating Scale,Wittenborn Scales,Edinburgh Postnatal Depression Scale,Mini International Neuropsychiatric Interview
D003865 Depressive Disorder, Major Disorder in which five (or more) of the following symptoms have been present during the same 2-week period and represent a change from previous functioning; at least one of the symptoms is either (1) depressed mood or (2) loss of interest or pleasure. Symptoms include: depressed mood most of the day, nearly every daily; markedly diminished interest or pleasure in activities most of the day, nearly every day; significant weight loss when not dieting or weight gain; Insomnia or hypersomnia nearly every day; psychomotor agitation or retardation nearly every day; fatigue or loss of energy nearly every day; feelings of worthlessness or excessive or inappropriate guilt; diminished ability to think or concentrate, or indecisiveness, nearly every day; or recurrent thoughts of death, recurrent suicidal ideation without a specific plan, or a suicide attempt. (DSM-5) Depression, Involutional,Major Depressive Disorder,Melancholia, Involutional,Paraphrenia, Involutional,Psychosis, Involutional,Depressive Disorders, Major,Involutional Depression,Involutional Melancholia,Involutional Paraphrenia,Involutional Paraphrenias,Involutional Psychoses,Involutional Psychosis,Major Depressive Disorders,Paraphrenias, Involutional,Psychoses, Involutional
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006854 Hydrocortisone The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. Cortef,Cortisol,Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-,11-Epicortisol,Cortifair,Cortril,Epicortisol,Hydrocortisone, (11 alpha)-Isomer,Hydrocortisone, (9 beta,10 alpha,11 alpha)-Isomer,11 Epicortisol
D000639 Amitriptyline Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines. Amineurin,Amitrip,Amitriptylin Beta,Amitriptylin Desitin,Amitriptylin RPh,Amitriptylin-Neuraxpharm,Amitriptyline Hydrochloride,Amitrol,Anapsique,Apo-Amitriptyline,Damilen,Domical,Elavil,Endep,Laroxyl,Lentizol,Novoprotect,Saroten,Sarotex,Syneudon,Triptafen,Tryptanol,Tryptine,Tryptizol,Amitriptylin Neuraxpharm,Apo Amitriptyline,Desitin, Amitriptylin,RPh, Amitriptylin

Related Publications

Michael Deuschle, and Bettina Hamann, and Cornelia Meichel, and Bertram Krumm, and Florian Lederbogen, and Anja Kniest, and Michael Colla, and Isabella Heuser
April 2001, Journal of clinical psychopharmacology,
Michael Deuschle, and Bettina Hamann, and Cornelia Meichel, and Bertram Krumm, and Florian Lederbogen, and Anja Kniest, and Michael Colla, and Isabella Heuser
March 1965, Ugeskrift for laeger,
Michael Deuschle, and Bettina Hamann, and Cornelia Meichel, and Bertram Krumm, and Florian Lederbogen, and Anja Kniest, and Michael Colla, and Isabella Heuser
April 2004, Journal of clinical psychopharmacology,
Michael Deuschle, and Bettina Hamann, and Cornelia Meichel, and Bertram Krumm, and Florian Lederbogen, and Anja Kniest, and Michael Colla, and Isabella Heuser
January 1989, Neuropsychobiology,
Michael Deuschle, and Bettina Hamann, and Cornelia Meichel, and Bertram Krumm, and Florian Lederbogen, and Anja Kniest, and Michael Colla, and Isabella Heuser
April 2002, Journal of clinical psychopharmacology,
Michael Deuschle, and Bettina Hamann, and Cornelia Meichel, and Bertram Krumm, and Florian Lederbogen, and Anja Kniest, and Michael Colla, and Isabella Heuser
June 1984, Archives of disease in childhood,
Michael Deuschle, and Bettina Hamann, and Cornelia Meichel, and Bertram Krumm, and Florian Lederbogen, and Anja Kniest, and Michael Colla, and Isabella Heuser
March 1985, Acta psychiatrica Scandinavica,
Michael Deuschle, and Bettina Hamann, and Cornelia Meichel, and Bertram Krumm, and Florian Lederbogen, and Anja Kniest, and Michael Colla, and Isabella Heuser
March 1986, Arzneimittel-Forschung,
Michael Deuschle, and Bettina Hamann, and Cornelia Meichel, and Bertram Krumm, and Florian Lederbogen, and Anja Kniest, and Michael Colla, and Isabella Heuser
December 1982, Clinical pharmacology and therapeutics,
Michael Deuschle, and Bettina Hamann, and Cornelia Meichel, and Bertram Krumm, and Florian Lederbogen, and Anja Kniest, and Michael Colla, and Isabella Heuser
December 1994, Journal of clinical psychopharmacology,
Copied contents to your clipboard!